World's Best Scientists 2026 revealed!
Domagoj Vucic

Domagoj Vucic

D-Index & Metrics

Biology and Biochemistry

D-Index
61
Citations
26703
World Ranking
11095
National Ranking
4799

Domagoj Vucic publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Domagoj Vucic sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 123 publications — 13th percentile

13% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Domagoj Vucic D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Domagoj Vucic sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 61 D-Index — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Domagoj Vucic is affiliated with Genentech in the United States and has contributed extensively to the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. Their research focuses primarily on molecular biology and immunology, with notable work in cancer research, epidemiology, and ophthalmology.

Their scholarly output spans a variety of topics related to cell death mechanisms and regulation, NF-κB signaling pathways, ubiquitin and proteasome pathways, interferon and immune responses, immune response and inflammation, inflammasome and immune disorders, as well as autophagy in disease and therapy.

  • Cell death mechanisms and regulation
  • NF-κB Signaling Pathways
  • Ubiquitin and proteasome pathways
  • interferon and immune responses
  • Immune Response and Inflammation
  • Inflammasome and immune disorders
  • Autophagy in Disease and Therapy

Vucic's frequent publication venues include:

  • FEBS Journal (15 publications)
  • Cell Death and Differentiation (4 publications)
  • Cell Death and Disease (3 publications)
  • The EMBO Journal (2 publications)
  • Science Signaling (2 publications)

Recent notable papers by Domagoj Vucic include:

  • Ubiquitination in the regulation of inflammatory cell death and cancer (2021, Cell Death and Differentiation)
  • Kinase inhibition in autoimmunity and inflammation (2020, Nature Reviews Drug Discovery)
  • The Balance of TNF Mediated Pathways Regulates Inflammatory Cell Death Signaling in Healthy and Diseased Tissues (2020, Frontiers in Cell and Developmental Biology)
  • Cell death pathways: intricate connections and disease implications (2021, The EMBO Journal)
  • The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxins (2020, Nature Genetics)

Frequent co-authors in their work consist of:

  • Séamus J. Martin
  • Dublin Chair
  • Andrey Abramov
  • Colin Adrain
  • Cecília M. Arraiano

Best Publications

  • Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

    Lorenzo Galluzzi;Ilio Vitale;Stuart A. Aaronson;John M. Abrams

  • Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf.

    Sanjeev Mariathasan;Kim Newton;Denise M. Monack;Domagoj Vucic

  • IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.

    Eugene Varfolomeev;John W. Blankenship;Sarah M. Wayson;Anna V. Fedorova

  • Ubiquitination in disease pathogenesis and treatment

    Doris Popovic;Domagoj Vucic;Ivan Dikic

  • Targeting IAP proteins for therapeutic intervention in cancer

    Simone Fulda;Domagoj Vucic

  • Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosis.

    Kim Newton;Debra L. Dugger;Katherine E. Wickliffe;Neeraj Kapoor

  • c-IAP1 and c-IAP2 Are Critical Mediators of Tumor Necrosis Factor α (TNFα)-induced NF-κB Activation

    Eugene Varfolomeev;Tatiana Goncharov;Anna V. Fedorova;Jasmin N. Dynek

  • ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas.

    Domagoj Vucic;Henning R. Stennicke;Maria Teresa Pisabarro;Guy S. Salvesen

  • Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death

    Domagoj Vucic;Vishva M. Dixit;Ingrid E. Wertz

  • RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury.

    K Newton;D L Dugger;A Maltzman;J M Greve

  • c‐IAP1 and UbcH5 promote K11‐linked polyubiquitination of RIP1 in TNF signalling

    Jasmin N Dynek;Tatiana Goncharov;Erin C Dueber;Anna V Fedorova

  • cIAP1 and TAK1 protect cells from TNF-induced necrosis by preventing RIP1/RIP3-dependent reactive oxygen species production

    N Vanlangenakker;T Vanden Berghe;P Bogaert;B Laukens

  • Molecular determinants of kinase pathway activation by Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand.

    Eugene Varfolomeev;Heather Maecker;Darcie Sharp;David Lawrence

  • Kinase inhibition in autoimmunity and inflammation

    Ali A. Zarrin;Katherine Bao;Patrick Lupardus;Domagoj Vucic

  • SMAC Negatively Regulates the Anti-apoptotic Activity of Melanoma Inhibitor of Apoptosis (ML-IAP)

    Domagoj Vucic;Kurt Deshayes;Heidi Ackerly;Maria Teresa Pisabarro

  • Ubiquitination in the regulation of inflammatory cell death and cancer.

    Peter E. Cockram;Matthias Kist;Sumit Prakash;Si-Han Chen

  • Discovery of a Potent Small-Molecule Antagonist of Inhibitor of Apoptosis (IAP) Proteins and Clinical Candidate for the Treatment of Cancer (GDC-0152).

    John A. Flygare;Maureen Beresini;Nageshwar Budha;Helen Chan

  • The Inhibitor of Apoptosis Proteins as Therapeutic Targets in Cancer

    Domagoj Vucic;Wayne J. Fairbrother

  • Targeting p21-activated kinase 1 (PAK1) to induce apoptosis of tumor cells

    Christy C. Ong;Adrian M. Jubb;Peter M. Haverty;Wei Zhou

  • Design, synthesis, and biological activity of a potent Smac mimetic that sensitizes cancer cells to apoptosis by antagonizing IAPs.

    Kerry Zobel;Lan Wang;Eugene Varfolomeev;Matthew C Franklin

Frequent Co-Authors

Simone Fulda
Simone Fulda Goethe University Frankfurt
Kim Newton
Kim Newton Genentech
Wyne P. Lee
Wyne P. Lee Genentech
John Silke
John Silke Walter and Eliza Hall Institute of Medical Research
Mathieu J.M. Bertrand
Mathieu J.M. Bertrand Ghent University
Peter Vandenabeele
Peter Vandenabeele Ghent University
Guy S. Salvesen
Guy S. Salvesen Sanford Burnham Prebys Medical Discovery Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degree options in Biology and Biochemistry opens up a broad range of career pathways in healthcare, research, and technology. Students interested in contributing to the growing digital health landscape can consider a HIM degree to combine knowledge of biology with health information systems and data management.

If nutritional science is your focus, finding the cheapest online nutrition degree can help you build expertise in dietetics and health promotion while keeping education costs manageable.

For students aiming for a clinical or diagnostic role, online sonography programs online and online rad tech programs provide flexible learning in high-demand medical imaging fields.

Many of these programs are designed for convenience and affordability, helping working professionals and recent graduates gain the skills needed for evolving healthcare jobs. Whether you pursue patient care, research, or technology-driven roles, online education offers a versatile path forward in biology and biochemistry-related careers.

Best Scientists Citing Domagoj Vucic

Trending Scientists

Recently Published Articles